新型冠状病毒肺炎与艰难梭菌感染：对老年患者的潜在影响。
COVID-19 and Clostridioides difficile infection (CDI): Possible implications for elderly patients.
机构信息
Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy; European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Study Group for Clostridioides difficile (ESGCD), Italy.
出版信息
Anaerobe. 2020 Aug;64:102233. doi: 10.1016/j.anaerobe.2020.102233. Epub 2020 Jun 25.
Abstract
COVID-19 dramatically affects the elderly. Due to the large usage of antibiotics during the current pandemic and the gastrointestinal manifestations of COVID-19, the elderly population, hospitalized patients, residents in LTCFs and persons that survived the COVID-19 might be more prone to Clostridioides difficile infections (CDI). A renewed attention to CDI is necessary during the ongoing COVID-19 pandemic.
摘要
COVID-19 对老年人影响巨大。由于当前大流行期间抗生素的大量使用以及 COVID-19 的胃肠道表现，老年人、住院患者、长期护理机构居民和 COVID-19 幸存者更易发生艰难梭菌感染（CDI）。在持续的 COVID-19 大流行期间，有必要重新关注 CDI。
相似文献
1
COVID-19 and Clostridioides difficile infection (CDI): Possible implications for elderly patients.新型冠状病毒肺炎与艰难梭菌感染：对老年患者的潜在影响。
Anaerobe. 2020 Aug;64:102233. doi: 10.1016/j.anaerobe.2020.102233. Epub 2020 Jun 25.
2
Clostridioides difficile infection (CDI) during the COVID-19 pandemic.艰难梭菌感染（CDI）在 COVID-19 大流行期间。
Anaerobe. 2022 Apr;74:102518. doi: 10.1016/j.anaerobe.2022.102518. Epub 2022 Jan 19.
3
Did Clostridioides difficile testing and infection rates change during the COVID-19 pandemic?艰难梭菌检测和感染率在 COVID-19 大流行期间是否发生了变化？
Anaerobe. 2021 Aug;70:102384. doi: 10.1016/j.anaerobe.2021.102384. Epub 2021 May 23.
4
[Reconsidering the technical aspects and quality management background of faecal microbiota transplantation due to the novel coronavirus pandemic].[鉴于新型冠状病毒大流行重新审视粪便微生物群移植的技术方面和质量管理背景]
Orv Hetil. 2020 Nov 1;161(44):1858-1871. doi: 10.1556/650.2020.32023.
5
Should we unstress SARS-CoV-2 infected cells?我们是否应该减轻感染了新冠病毒的细胞的应激反应？
Cytokine Growth Factor Rev. 2020 Aug;54:3-5. doi: 10.1016/j.cytogfr.2020.06.011. Epub 2020 Jun 11.
6
Clostridioides difficile in COVID-19 Patients, Detroit, Michigan, USA, March-April 2020.2020 年 3 月-4 月，美国密歇根州底特律市，COVID-19 患者中的艰难梭菌。
Emerg Infect Dis. 2020 Sep;26(9):2272-4. doi: 10.3201/eid2609.202126. Epub 2020 May 22.
7
Our experience with 80 cases of SARS-CoV-2-Clostridioides difficile co-infection: An observational study.我们对 80 例 SARS-CoV-2-艰难梭菌合并感染的经验：一项观察性研究。
Medicine (Baltimore). 2022 Jul 8;101(27):e29823. doi: 10.1097/MD.0000000000029823.
8
Healthcare-associated infection during the COVID-19 pandemic in a tertiary care hospital in Romania.罗马尼亚一家三级保健医院在 COVID-19 大流行期间的医源性感染。
Rom J Intern Med. 2021 Nov 20;59(4):409-415. doi: 10.2478/rjim-2021-0020. Print 2021 Dec 1.
9
Risk factors for complicated course and recurrence of Clostridioides Difficile infections during COVID-19 pandemic.COVID-19 大流行期间艰难梭菌感染复杂病程和复发的危险因素。
Przegl Epidemiol. 2022;77(1):23-33. doi: 10.32394/pe.77.02.
10
Severe colitis as potential late complication associated with COVID-19.严重结肠炎作为与COVID-19相关的潜在晚期并发症。
Ann R Coll Surg Engl. 2020 Sep;102(7):e176-e179. doi: 10.1308/rcsann.2020.0166. Epub 2020 Aug 17.
引用本文的文献
1
infection epidemiology during the COVID-19 pandemic in Greece.在 COVID-19 大流行期间希腊的传染病流行病学。
Future Microbiol. 2024 Sep;19(13):1119-1127. doi: 10.1080/17460913.2024.2358653. Epub 2024 Jun 24.
2
Knowledge, attitude, and practice (KAP) of antimicrobial prescription and its resistance among health care providers in the COVID-19 era: A cross sectional study.在 COVID-19 时代，医疗保健提供者对抗菌药物处方及其耐药性的知识、态度和实践（KAP）：一项横断面研究。
PLoS One. 2023 Aug 10;18(8):e0289711. doi: 10.1371/journal.pone.0289711. eCollection 2023.
3
Real-World Budget Impact of Fidaxomicin versus Vancomycin or Metronidazole for In-Hospital Treatment of Clostridioides difficile Infection.非达霉素与万古霉素或甲硝唑用于艰难梭菌感染住院治疗的真实世界预算影响
Antibiotics (Basel). 2023 Jan 6;12(1):106. doi: 10.3390/antibiotics12010106.
4
The impact of coronavirus disease 2019 (COVID-19) on the antimicrobial stewardship pharmacist workforce: A multicenter survey.2019年冠状病毒病（COVID-19）对抗菌药物管理药师队伍的影响：一项多中心调查。
Antimicrob Steward Healthc Epidemiol. 2022 Apr 7;2(1):e56. doi: 10.1017/ash.2022.37. eCollection 2022.
5
Infection before and during Coronavirus Disease 2019 Pandemic-Similarities and Differences.2019冠状病毒病大流行之前及期间的感染——异同之处
Microorganisms. 2022 Nov 17;10(11):2284. doi: 10.3390/microorganisms10112284.
6
Long-Term Lactulose Administration Improves Dysbiosis Induced by Antibiotic and in the PathoGut SHIME Model.长期服用乳果糖可改善抗生素诱导的肠道菌群失调及PathoGut SHIME模型中的肠道菌群失调。
Antibiotics (Basel). 2022 Oct 24;11(11):1464. doi: 10.3390/antibiotics11111464.
7
Antibiotic prescribing patterns among patients admitted to an academic teaching hospital for COVID-19 during the first wave of the pandemic in Toronto: A retrospective, controlled study.多伦多疫情第一波期间因新冠肺炎入住一所学术教学医院的患者的抗生素处方模式：一项回顾性对照研究。
J Assoc Med Microbiol Infect Dis Can. 2022 Feb 24;7(1):14-22. doi: 10.3138/jammi-2021-0020. eCollection 2022 Mar.
8
infection epidemiology and clinical characteristics in COVID-19 pandemic.新型冠状病毒肺炎大流行中的感染流行病学及临床特征
Front Med (Lausanne). 2022 Aug 22;9:953724. doi: 10.3389/fmed.2022.953724. eCollection 2022.
9
Characterization of Strains from an Outbreak Using MALDI-TOF Mass Spectrometry.使用基质辅助激光解吸电离飞行时间质谱法对一次疫情中的菌株进行鉴定
Microorganisms. 2022 Jul 21;10(7):1477. doi: 10.3390/microorganisms10071477.
10
Risk Factors for Hospital Readmission for Infection: A Statewide Retrospective Cohort Study.感染导致再次入院的风险因素：一项全州范围的回顾性队列研究。
Pathogens. 2022 May 8;11(5):555. doi: 10.3390/pathogens11050555.
本文引用的文献
1
Co-infections: potentially lethal and unexplored in COVID-19.合并感染：在新冠病毒病中可能致命且未被探索。
Lancet Microbe. 2020 May;1(1):e11. doi: 10.1016/S2666-5247(20)30009-4. Epub 2020 Apr 24.
2
Covid-19 induced superimposed bacterial infection.新冠病毒感染引发的叠加细菌感染。
J Biomol Struct Dyn. 2021 Jul;39(11):4185-4191. doi: 10.1080/07391102.2020.1772110. Epub 2020 Jun 9.
3
Clostridioides difficile in COVID-19 Patients, Detroit, Michigan, USA, March-April 2020.2020 年 3 月-4 月，美国密歇根州底特律市，COVID-19 患者中的艰难梭菌。
Emerg Infect Dis. 2020 Sep;26(9):2272-4. doi: 10.3201/eid2609.202126. Epub 2020 May 22.
4
COVID-19: don't neglect antimicrobial stewardship principles!2019冠状病毒病：勿忽视抗菌药物管理原则！
Clin Microbiol Infect. 2020 Jul;26(7):808-810. doi: 10.1016/j.cmi.2020.04.024. Epub 2020 Apr 30.
5
Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.细菌和真菌合并感染冠状病毒的个体：一项支持 COVID-19 抗菌药物处方的快速综述。
Clin Infect Dis. 2020 Dec 3;71(9):2459-2468. doi: 10.1093/cid/ciaa530.
6
SARS-CoV-2 productively infects human gut enterocytes.SARS-CoV-2 能有效地感染人类肠道肠细胞。
Science. 2020 Jul 3;369(6499):50-54. doi: 10.1126/science.abc1669. Epub 2020 May 1.
7
COVID-19: towards understanding of pathogenesis.新型冠状病毒肺炎：对发病机制的认识
Cell Res. 2020 May;30(5):367-369. doi: 10.1038/s41422-020-0327-4.
8
Digestive Symptoms in COVID-19 Patients With Mild Disease Severity: Clinical Presentation, Stool Viral RNA Testing, and Outcomes.轻度疾病严重程度的 COVID-19 患者的消化症状：临床表型、粪便病毒 RNA 检测和结局。
Am J Gastroenterol. 2020 Jun;115(6):916-923. doi: 10.14309/ajg.0000000000000664.
9
COVID-19 and the gastrointestinal tract: more than meets the eye.新型冠状病毒肺炎与胃肠道：远不止表面所见。
Gut. 2020 Jun;69(6):973-974. doi: 10.1136/gutjnl-2020-321195. Epub 2020 Apr 9.
10
Clinical features of deaths in the novel coronavirus epidemic in China.中国新型冠状病毒疫情死亡患者的临床特征。
Rev Med Virol. 2020 May;30(3):e2103. doi: 10.1002/rmv.2103. Epub 2020 Mar 16.
Zotero 插件